Key result
AGE-RAGE pathway activation in DCM fibroblasts identifies TGFB2 as a key biomarker and fibrotic regulator.
Why the study?
The molecular underpinnings of dilated cardiomyopathy are not fully defined, and the involvement of AGE-RAGE signaling in its pathogenesis remains largely unexplored.
The AGE-RAGE pathway exhibits cell-type-specific activation in fibroblasts of dilated cardiomyopathy, and genes such as TGFB2, MYH6, and MYH10 may serve as potential diagnostic biomarkers.
Answers are grounded in this paper and cite their sources.
Does not yet alter DCM care; leaves open AGE-RAGE as a therapeutic target pending functional validation.
Dilated cardiomyopathy (DCM) presents with ventricular dilation and systolic dysfunction, yet its molecular underpinnings are not fully defined. The involvement of AGE-RAGE signaling in DCM pathogenesis remains largely unexplored. The differential engagement of this pathway in DCM was investigated, and responsible cell subsets and candidate molecular mediators were identified. This study integrated bulk RNA-seq data (GSE57338, GSE141910, GSE165303) and single-cell RNA-seq data (GSE183852). Supplementary analyses of cardiomyocyte populations from single-nucleus RNA-seq (snRNA-seq) data of GSE183852 were further performed. Using differential expression analysis, pathway enrichment analysis, cell clustering, GSVA, transcription factor regulatory network construction and other approaches, this study systematically characterized the activation pattern of the AGE-RAGE pathway in DCM. Key molecular expression and functional roles were validated in primary cardiac fibroblast experiments. The activity of the AGE-RAGE pathway was elevated in DCM, with a more pronounced effect observed in fibroblasts. MYH6, MYH10, and TGFB2 were identified as critical diagnostic genes for DCM, exhibiting robust diagnostic performance across multiple datasets. Single-cell analysis revealed that TGFB2 was highly expressed in the fibroblast subpopulation Fib1. Functional experiments confirmed that TGF-β1-induced fibrotic responses depend on AGE-RAGE pathway activation, which could be reversed by the RAGE inhibitor FPS-ZM1. This study suggests that the AGE-RAGE pathway exhibits cell-type-specific activation characteristics in fibroblasts of DCM, and indicates that genes such as TGFB2 may serve as potential biomarkers for DCM. These findings provide novel insights into the cellular and molecular mechanisms underlying DCM.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied Dilated cardiomyopathy (DCM). AGE-RAGE pathway activation and TGFB2 expression vs. Healthy controls / untreated cells was evaluated. The AGE-RAGE pathway exhibits cell-type-specific activation in cardiac fibroblasts of patients with dilated cardiomyopathy, with TGFB2 identified as a key diagnostic biomarker and upstream regulator of fibrotic responses.
Synapse has enriched 10 related papers. Consider them for comparative context: